ZOFRASET ondansetron (as hydrochloride dihydrate) 4 mg/2 mL solution for injection pre-filled syringe

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

即購入

公開評価報告書 公開評価報告書 (PAR)
11-01-2021

有効成分:

ondansetron hydrochloride dihydrate, Quantity: 4.99 mg (Equivalent: ondansetron, Qty 4 mg)

から入手可能:

Accord Healthcare Pty Ltd

医薬品形態:

Injection, solution

構図:

Excipient Ingredients: citric acid monohydrate; sodium citrate dihydrate; sodium hydroxide; water for injections; hydrochloric acid; sodium chloride

投与経路:

Intramuscular, Intravenous

パッケージ内のユニット:

Pack of 1 pre-filled syringe

処方タイプ:

(S4) Prescription Only Medicine

適応症:

Ondansetron injection is indicated ? For the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. ? For the prevention and treatment of post-operative nausea and vomiting.

製品概要:

Visual Identification: Clear, colourless solution in an amber glass pre-filled syringe; Container Type: Syringe; Container Material: Glass Type I Coloured; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

認証ステータス:

Registered

承認日:

2020-11-09